Press Releases

05.19.2025

Pfizer Enters into Exclusive Licensing Agreement with 3SBio

04.24.2025

Pfizer Announces 2025 Shareholder Meeting Preliminary Results

04.10.2025

Pfizer Invites Shareholders to Attend Virtual 2025 Annual Meeting of Shareholders on April 24

12.17.2024

Pfizer Provides Full-Year 2025 Guidance and Reaffirms Full-Year 2024 Guidance

12.10.2024

Arvinas and Pfizer Announce Initial Phase 1b Data from the TACTIVE-U Sub-Study of Vepdegestrant in Combination with Abemaciclib at 2024 San Antonio Breast Cancer Symposium

11.20.2024

Pfizer Announces New Chief Scientific Officer and President, Research & Development

10.15.2024

Tim Buckley Elected to Pfizer’s Board of Directors

08.27.2024

Pfizer Launches PfizerForAll™, a Digital Platform that Helps Simplify Access to Healthcare

07.09.2024

Pfizer to Launch Process to Identify a Successor for Dr. Mikael Dolsten, Chief Scientific Officer and President, Pfizer Research & Development

04.25.2024

Pfizer Announces 2024 Shareholder Meeting Preliminary Results

04.24.2024

Pfizer Declares Second-Quarter 2024 Dividend

04.11.2024

Pfizer Invites Shareholders to Attend Virtual-Only 2024 Annual Meeting of Shareholders on April 25